|  | 
| 
				Maximum: 									6 CME cr.								 0 new discussion posts (2 published) Sign in to view your progression | 
The ESGO-ENYGO-ESO Masterclass in Gynaecological Oncology (24/06/2021-25/06/2021) has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) for a maximum of 6 European CME credits (ECMEC®s).
Each medical specialist should claim only those credits that he/she actually spent in the educational activity. The EACCME® is an institution of the European Union of Medical Specialists (UEMS), www.uems.eu.
Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 Credits™.
Information on the process to convert EACCME® credits to AMA credits can be found at www.ama-assn.org/education/earn-credit-participation-international-activities. Live educational activities occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC® credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.
| Vulvar cancer |  | 
| Cervical cancer |  | 
| Malignant tumours of the uterus |  | 
| Malignant tumours of the ovaries |  | 
| Masterclass in Gynaecological Oncology | DAY 1  - June 24th, 2021 - 15:00 - 18:10 CET (This live session is over) |  | 
| Masterclass in Gynaecological Oncology | DAY 2  - June 25th, 2021 - 15:00 - 18:15 CET (This live session has ended) |  | 
| Evaluation and Certificate (*Mandatory to obtain CME certificate) |  | 
 
                             
        
 
                 
                 
                     
                     
                     
                                 
                     
                                 
                     
                     
                     
                                 
                     
                                 
                     
                                 
                     
                     
                                 
                     
                                 
                     
                     
                                                     
                                                    